The antimanic-like effect of tamoxifen: Behavioural comparison with other PKC-inhibiting and antiestrogenic drugs

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 8, 2008, Pages 1927-1931

  Sabioni, Pamela ^a   Baretta, Irinéia P ^a,b   Ninomiya, Ester M ^a   Gustafson, Lianna ^a   Rodrigues, Ana Lúcia S ^c   Andreatini, Roberto ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b UNIVERSIDADE PARANAENSE   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Amphetamine; Animal model; Manic; Mice; Mood stabilizer

Indexed keywords

AMPHETAMINE; CHELERYTHRINE; LITHIUM CARBONATE; MEDROXYPROGESTERONE ACETATE; PROTEIN KINASE C; TAMOXIFEN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HYPERACTIVITY; MALE; MANIA; MOOD; MOUSE; NONHUMAN; TRANQUILIZING ACTIVITY;

AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; ANTIMANIC AGENTS; BEHAVIOR, ANIMAL; BENZOPHENANTHRIDINES; CONTRACEPTIVES, ORAL, SYNTHETIC; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; HYPERKINESIS; LITHIUM CARBONATE; MEDROXYPROGESTERONE; MICE; PROTEIN KINASE C; TAMOXIFEN;

EID: 56749183610     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.09.023     Document Type: Article

References (32)

1. Almeida R.C., Souza D.G., Soletti R.C., López M.G., Rodrigues A.L.S., and Gabilan N.H. Involvement of PKA, MAPK/ERK and CaMKII, but not PKC in the acute antidepressant-like effect of memantine in mice. Neurosci Lett 395 (2006) 93-97
2. Bebchuk J.M., Arfken C.L., Dolan-Mangi S., Murphy J., Hasanak K., and Manji H.K. A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania. Arch Gen Psychiatry 57 (2000) 95-97
3. Bethea C.L., Mirkes S.J., Shively C.A., and Adams M.R. Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques. Biol Psychiatry 47 6 (2000) 562-576
4. Browman K.E., Kantor L., Richardson S., Badiani A., Robinson T.E., and Gnegy M.E. Injections of protein kinase C inhibitor Ro31-8220 into the nucleus accumbens attenuates the acute response to amphetamine: tissue and behavior studies. Brain Res 814 (1998) 112-119
5. Brunello N. Mood stabilizers: protecting the mood... protecting the brain. J Affect Disord 79 (2004) 15-20
6. Chouinard G., Steinberg S., and Steiner W. Estrogen-progesterone combination: another mood stabilizer. Am J Psychiatry 144 6 (1987) 826
7. Einat H. Modelling facets of mania - new directions related to the notion of endophenotypes. J Psychopharmacologia 20 5 (2006) 714-722
8. Einat H. Different behaviors and different strains: potential new ways to model bipolar disorder. Neurosci Biobehav Rev 31 6 (2007) 850-857
9. Einat H., Yuan P., Szabo S., Dogra S., and Manji H.K. Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder. Neuropsychobiology 55 (2007) 123-131
10. Fujimoto J., Hori M., Ichigo S., Hirose R., and Tamaya T. Antiestrogenic compounds inhibit estrogen-induced expressions of basic fibroblast growth factor and its mRNA in well-differentiated endometrial cancer cells. Gen Pharmacol 28 2 (1997) 215-219
11. Goldstein J.A. Danazol and the rapid-cycling patient. J Clin Psychiatry 47 3 (1986) 153-154
12. Gould T.J., Keith R.A., and Bhat R.V. Differential sensitivity to lithium's reversal of amphetamine-induced open-field in two inbred strains of mice. Behav Brain Res 118 (2001) 95-105
13. Gould T.D., O'Donnell K.C., Picchini A.M., and Manji H.K. Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium. Neuropsychopharmacology 32 6 (2006) 1321-1333
14. Hahn C.G., and Friedman E. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder. Bipolar Disord 2 (1999) 81-86
15. Hahn C.G., Umapathy, Wang H.Y., Koneru R., Levinson D.F., and Friedman E. Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients. J Psychiatr Res 39 4 (2005) 355-363
16. Kelly P.H., and Iversen S.D. Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40 1 (1976) 45-56
17. Kelly P.H., and Roberts D.C. Effects of amphetamine and apomorphine on locomotor activity after 6-OHDA and electrolytic lesions of the nucleus accumbens septi. Pharmacol Biochem Behav 19 1 (1983) 137-143
18. Kulkarni J., Garland K.A., Scaffidi A., Headey A., Anderson R., Castella A., et al. A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder. Psychoneuroendocrinology 31 (2006) 543-547
19. Kulkarni J., Gurvich C., Gilbert H., Mehmedbegovic F., Mu L., Marston N., et al. Hormone modulation: a novel therapeutic approach for women with severe mental illness. Aust N Z J Psychiatry 42 1 (2008) 83-88
20. Laursen E.E., and Belknap J.K. Intracerebroventricular injections in mice some methodological refinements. J Pharmacol Methods 16 (1986) 155-157
21. Machado-Vieira R., Kapczinski F., and Soares J.C. Perspectives for the development of animal models of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 28 2 (2004) 209-224
22. Manji H.K., and Chen G. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers. Mol Psychiatry 7 (2002) 46-56 [Suppl 1]
23. Manji H.K., and Lenox R.H. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry 46 (1999) 1328-1351
24. Mickley K.R., and Dluzen D.E. Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice. Neuroendocrinology 79 6 (2004) 305-316
25. Nicoletti F., Speciale C., Sortino M.A., Summa G., Caruso G., Patti F., et al. Comparative effects of estradiol benzoate, the antiestrogen clomiphene citrate, and the progestin medroxyprogesterone acetate on kainic acid-induced seizures in male and female rats. Epilepsia 26 3 (1985) 252-257
26. Pazol K., Wilson M.E., and Wallen K. Medroxyprogesterone acetate antagonizes the effects of estrogen treatment on social and sexual behavior in female macaques. J Clin Endocrinol Metab 89 6 (2004) 2998-3006
27. Tepper R., Bar J., Goldberger S., Fuchs J., Beyth Y., and Ovadia J. The effect of medroxyprogesterone acetate and clomiphene citrate on platelet function in menopausal women. Maturitas 24 1-2 (1996) 51-56
28. Tohen M. Clinical trials in bipolar mania: implications in study design and drug development. Arch Gen Psychiatry 65 3 (2008) 252-253
29. Yates J.W., Meij J.T., Sullivan J.R., Richtand N.M., and Yu L. Bimodal effect of amphetamine on motor behaviors in C57BL/6 mice. Neurosci Lett 427 1 (2007) 66-70
30. Yildiz A., Guleryuz S., Ankerst D.P., Ongür D., and Renshaw P.F. Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. Arch Gen Psychiatry 65 3 (2008) 255-263
31. Xiao L., Jackson L.R., and Becker J.B. The effect of estradiol in the striatum is blocked by ICI 182,780 but not tamoxifen: pharmacological and behavioral evidence. Neuroendocrinology 77 4 (2003) 239-245
32. Zarate Jr. C.A., Singh J.B., Carlson F.J., Quiroz J., Jolkovsky L., Luckenbaugh D.A., et al. Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Bipolar Disord 9 (2007) 561-570